Agenus Inc. (AGEN) P/E Ratio History
Historical price-to-earnings valuation from 2022 to 2022
Loading P/E history...
AGEN Valuation Context
How does the current P/E compare to historical and market benchmarks?
P/E Ratio Analysis
As of May 8, 2026, Agenus Inc. (AGEN) trades at a price-to-earnings ratio of -1102.9x, with a stock price of $3.75 and trailing twelve-month earnings per share of $0.00.
The current P/E is 2260% below its 5-year average of 51.1x. Over the past five years, AGEN's P/E has ranged from a low of 51.1x to a high of 51.1x, placing the current valuation at the 0th percentile of its historical range.
Compared to the Healthcare sector median P/E of 22.3x, AGEN trades at a 5041% discount to its sector peers. The sector includes 241 companies with P/E ratios ranging from 0.0x to 177.5x.
Relative to the broader market, AGEN trades at a notable discount to the S&P 500 median P/E of 25.1x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our AGEN DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
AGEN P/E vs Peers
P/E ratio compared to closely matched public peers
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $20B | 15.3Lowest | - | +4173%Best | |
| $12B | 16.6 | 0.32Best | +58% | |
| $6B | 24.8 | - | -34% | |
| $7B | 15.5 | - | +1747% |
Peers sorted by market capitalization. P/E below peers may indicate undervaluation or lower growth expectations. Consider PEG ratio for growth-adjusted comparison.
AGEN Historical P/E Data (2022–2022)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Date | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2022 Q2 | $38.80 | $0.76 | 51.1x | +0% |
Average P/E for displayed period: 51.1x
See AGEN's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs AGEN Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare AGEN vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonAGEN — Frequently Asked Questions
Quick answers to the most common questions about buying AGEN stock.
Is AGEN stock overvalued or undervalued?
AGEN trades at -1102.9x P/E, below its 5-year average of 51.1x. At the N/A percentile of historical range, the stock is priced at a discount to its own history.
How does AGEN's valuation compare to peers?
Agenus Inc. P/E of -1102.9x compares to sector median of 22.3x. The discount suggests lower growth expectations or higher risk.
What is AGEN's PEG ratio?
AGEN PEG ratio is N/A. Above 2.0 indicates premium valuation relative to growth rate. Historical P/E data spans 2022-2022.